Tech Company Financing Transactions
Aria Diagnostics Funding Round
On 1/10/2012, Aria Diagnostics raised $52.7 million in Series C funding from Domain Associates, Meritech Capital Partners and Venrock.
Transaction Overview
Company Name
Announced On
1/10/2012
Transaction Type
Venture Equity
Amount
$52,700,000
Round
Series C
Investors
Proceeds Purpose
Aria will use the funds to support product development and prepare commercialization of its proprietary prenatal test to detect common fetal trisomies such as Trisomy 21, which is associated with Down syndrome.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5945 Optical Ct.
San Jose, CA 95138
USA
San Jose, CA 95138
USA
Phone
Website
Email Address
Overview
Aria Diagnostics is a privately funded biotechnology company based on a strong scientific foundation. Our novel blood tests equip pregnant women with the right information to make decisions regarding the health of their baby and their own body.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
John Stuelpnagel
Chief Executive Officer
Ken Song
Chief Scientific Officer
Arnold Oliphant
VP - Finance
Dan Puckett
VP - General Counsel
Dianna DeVore
VP - Marketing
Margaret Theeuwes
VP - Operations
Andrew Sparks
VP - Sales
Todd Whitson
Browse more venture capital transactions:
Prev: 1/10/2012: Zmags venture capital transaction
Next: 1/10/2012: Verivo Software venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs